Cargando…

Association between hepatic steatosis and the development of hepatocellular carcinoma in patients with chronic hepatitis B

BACKGROUND/AIMS: Nonalcoholic fatty liver disease (NAFLD) is becoming a worldwide epidemic, and is frequently found in patients with chronic hepatitis B (CHB). We investigated the impact of histologically proven hepatic steatosis on the risk for hepatocellular carcinoma (HCC) in CHB patients without...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Yun Bin, Ha, Yeonjung, Chon, Young Eun, Kim, Mi Na, Lee, Joo Ho, Park, Hana, Kim, Kwang-il, Kim, Soo-Hwan, Rim, Kyu Sung, Hwang, Seong Gyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association for the Study of the Liver 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6435969/ https://www.ncbi.nlm.nih.gov/pubmed/30360031 http://dx.doi.org/10.3350/cmh.2018.0040

Ejemplares similares

Hepatocellular carcinoma and death and transplantation in chronic hepatitis B treated with entecavir or tenofovir disoproxil fumarate
por: Ha, Yeonjung, et al.
Publicado: (2020)

Cirrhosis, Age, and Liver Stiffness-Based Models Predict Hepatocellular Carcinoma in Asian Patients with Chronic Hepatitis B
por: Lim, Jihye, et al.
Publicado: (2021)

Changes in liver stiffness values assessed using transient elastography in chronic hepatitis B patients treated with tenofovir disoproxil fumarate: a prospective observational study
por: Cho, Heejin, et al.
Publicado: (2023)

Validation of the Liver Disease Quality of Life Instrument 1.0 in Patients with Chronic Hepatitis B: A Prospective Study
por: Ha, Yeonjung, et al.
Publicado: (2019)

Sarcopenia Predicts Prognosis in Patients with Newly Diagnosed Hepatocellular Carcinoma, Independent of Tumor Stage and Liver Function
por: Ha, Yeonjung, et al.
Publicado: (2018)

Development of a New Nomogram Including Neutrophil-to-Lymphocyte Ratio to Predict Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
por: Chon, Young Eun, et al.
Publicado: (2019)

Decrease in waist-to-hip ratio reduced the development of chronic kidney disease in non-obese non-alcoholic fatty liver disease
por: Chon, Young Eun, et al.
Publicado: (2020)

Hepatitis B Core Antigen Expression in Hepatocytes Reflects Viral Response to Entecavir in Chronic Hepatitis B Patients
por: Lee, Jeong Guil, et al.
Publicado: (2013)

The relationship between visceral obesity and hepatic steatosis measured by controlled attenuation parameter
por: Lee, Hye Won, et al.
Publicado: (2017)

Predictive biomarkers of survival in patients with advanced hepatocellular carcinoma receiving atezolizumab plus bevacizumab treatment
por: Chon, Young Eun, et al.
Publicado: (2022)

Atezolizumab/Bevacizumab vs. Lenvatinib as First-Line Therapy for Unresectable Hepatocellular Carcinoma: A Real-World, Multi-Center Study
por: Kim, Beom Kyung, et al.
Publicado: (2022)

The Association between Vitamin D Insufficiency and Nonalcoholic Fatty Liver Disease: A Population-Based Study
por: Ha, Yeonjung, et al.
Publicado: (2017)

Influence of hepatic steatosis on the outcomes of patients with chronic hepatitis B treated with entecavir and tenofovir
por: Kim, David Sooik, et al.
Publicado: (2019)

Variation in the Dicer and RAN Genes Are Associated with Survival in Patients with Hepatocellular Carcinoma
por: Kim, Mi Na, et al.
Publicado: (2016)

Factors Affecting the Accuracy of Controlled Attenuation Parameter (CAP) in Assessing Hepatic Steatosis in Patients with Chronic Liver Disease
por: Jung, Kyu Sik, et al.
Publicado: (2014)

The association of hepatic steatosis and fibrosis with heart failure and mortality
por: Park, Jiyun, et al.
Publicado: (2021)

A Disintegrin and Metalloproteinase 9 (ADAM9) in Advanced Hepatocellular Carcinoma and Their Role as a Biomarker During Hepatocellular Carcinoma Immunotherapy
por: Oh, Sooyeon, et al.
Publicado: (2020)

Umbelliferone Ameliorates Hepatic Steatosis and Lipid-Induced ER Stress in High-Fat Diet-Induced Obese Mice
por: Park, Na Won, et al.
Publicado: (2023)

A critical role of hepatitis B virus polymerase in cirrhosis, hepatocellular carcinoma, and steatosis
por: Chung, Hea‐Jong, et al.
Publicado: (2017)

Granulocyte Colony Stimulating Factor Ameliorates Hepatic Steatosis Associated with Improvement of Autophagy in Diabetic Rats
por: Joo, Hyun-Woo, et al.
Publicado: (2020)

Identification of hepatic steatosis in living liver donors by machine learning models
por: Lim, Jihye, et al.
Publicado: (2022)

Feasibility of non-enhanced CT for assessing longitudinal changes in hepatic steatosis
por: Kim, Min Gi, et al.
Publicado: (2019)

Effects of Metabolic Syndrome on Fibrosis in Chronic Viral Hepatitis
por: Yoon, Harry, et al.
Publicado: (2013)

Predicting Hepatic Steatosis in Living Liver Donors via Noninvasive Methods
por: Kim, Jong Man, et al.
Publicado: (2016)

Body weight variability and the risk of cardiovascular outcomes in patients with nonalcoholic fatty liver disease
por: Kim, Mi Na, et al.
Publicado: (2021)

Association between severe hepatic steatosis examined by Fibroscan and the risk of high-risk colorectal neoplasia
por: Kim, Kwang Woo, et al.
Publicado: (2022)

Hepatic Subcapsular Steatosis in a Diabetic CAPD Patient Receiving Intraperitoneal Insulin
por: Jang, Eun Chul, et al.
Publicado: (2006)

Hepatocellular Carcinoma in a Patient With Hepatic Steatosis
por: Romano, John, et al.
Publicado: (2020)

α-Mangostin ameliorates hepatic steatosis and insulin resistance by inhibition C-C chemokine receptor 2
por: Kim, Hong Min, et al.
Publicado: (2017)

Molecular Epidemiology of Hepatitis A Virus in the South-East Area of Gyeonggi-do in Korea
por: Song, Han Ul, et al.
Publicado: (2009)

Liver intravoxel incoherent motion diffusion-weighted imaging for the assessment of hepatic steatosis and fibrosis in children
por: Shin, Hyun Joo, et al.
Publicado: (2018)

Interaction between the PNPLA3 Gene and Nutritional Factors on NAFLD Development: The Korean Genome and Epidemiology Study
por: Oh, Sooyeon, et al.
Publicado: (2022)

Treatment of growth hormone attenuates hepatic steatosis in hyperlipidemic mice via downregulation of hepatic CD36 expression
por: Jang, Hyung Seok, et al.
Publicado: (2020)

Hepatic Steatosis Index in the Detection of Fatty Liver in Patients with Chronic Hepatitis B Receiving Antiviral Therapy
por: Chang, Jin Won, et al.
Publicado: (2021)

Fermented mulberry (Morus alba) leaves suppress high fat diet-induced hepatic steatosis through amelioration of the inflammatory response and autophagy pathway
por: Lee, Mi Rim, et al.
Publicado: (2020)

How does hepatic steatosis affect the outcome of patients with chronic hepatitis B?
por: Yu, Jung Hwan, et al.
Publicado: (2019)

Peroxisome proliferator-activated receptor δ agonist attenuates hepatic steatosis by anti-inflammatory mechanism
por: Lee, Mi Young, et al.
Publicado: (2012)

C-C Chemokine Receptor 2 Inhibitor Ameliorates Hepatic Steatosis by Improving ER Stress and Inflammation in a Type 2 Diabetic Mouse Model
por: Kim, Hong-Min, et al.
Publicado: (2015)

Serotonin signals through a gut-liver axis to regulate hepatic steatosis
por: Choi, Wonsuk, et al.
Publicado: (2018)

Differing Associations between Fatty Liver and Dyslipidemia According to the Degree of Hepatic Steatosis in Korea
por: Han, Ji Min, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qprkqv2kkee786t109m0b2m2ce